Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 70,000 shares at $8.00 ($560K) on 2015-03-03, disclosed to the SEC on 2015-03-04.
Open-market sale of $560k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |